Price loading...

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States

Price data last checked 103 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
98% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India

£515.00 05 Feb 2026
The 2023-2028 Outlook for Respiratory Disorder Treatments in the United States
98% match

The 2023-2028 Outlook for Respiratory Disorder Treatments in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
98% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India

£515.00 05 Feb 2026
The 2023-2028 World Outlook for Pulmonary Fibrosis Treatments
98% match

The 2023-2028 World Outlook for Pulmonary Fibrosis Treatments

Out of Stock 13 Jan 2026
The 2023-2028 Outlook for Asthma Treatments in the United States
97% match

The 2023-2028 Outlook for Asthma Treatments in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
97% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
97% match

The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis Treatments

Out of Stock 08 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States
97% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
97% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
97% match

The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis Treatments

£790.00 14 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
97% match

The 2023-2028 Outlook for Amyloidosis Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Osteoporosis Treatments in the United States
97% match

The 2023-2028 Outlook for Osteoporosis Treatments in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Plantar Fasciitis Treatments in the United States
96% match

The 2023-2028 Outlook for Plantar Fasciitis Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States

£520.00 26 Feb 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Air Treatment Products in the United States
96% match

The 2023-2028 Outlook for Air Treatment Products in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
96% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States

£520.00 03 Feb 2026
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States
96% match

The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis
96% match

The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis

Out of Stock 06 Jan 2026
The 2023-2028 Outlook for Pseudomonas Aeruginosa Infection Treatments in the United States
96% match

The 2023-2028 Outlook for Pseudomonas Aeruginosa Infection Treatments in the United States

£520.00 16 Feb 2026
The 2023-2028 Outlook for Respiratory Disorder Treatments in India
96% match

The 2023-2028 Outlook for Respiratory Disorder Treatments in India

£515.00 08 Feb 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
96% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 14 Jan 2026